Publicly-Funded Covid-19 Treatment Paxlovid™

Paxlovid™ (nirmatrelvir/ritonavir) is an oral antiviral medication used to treat mild to moderate COVID-19 infection in adults who are at high risk of progressing to serious disease. It is intended to be used as soon as possible after diagnosis and within 5 days of symptom onset. You have to obtain a PRESCRIPTION from your physician first before you can access publicly-funded Paxlovid™ from our pharmacy. 

 

AFTER you obtain your prescription from your physician:

1. If you are not our existing patient (ie. you do not pick up prescriptions from us), please confirm our supply first before sending us a prescription.   

2. Please fill out Paxlovid™ Assessment Intake Form.  Paxlovid™ has many potential serious drug-drug interactions, so our pharmacist will refuse to dispense Paxlovid™ to you without knowing your full medical and medication history. Please email your assessment form to general@townlinepharmacy.ca

3. We will reach out to you to make an appointment for Paxlovid Consultation by phone. Please note that we do NOT provide Paxlovid consultation on Wednesdays

4. At your phone call appointment, our pharmacist will call you to review your file, which may take 30min-1 hour depending on how complex your situation is.  Some of your regular medications may need to be adjusted. 

5. After the consultation, please send an asymptomatic person to bring in the original copy of prescription and to pick up the medication on your behalf since symptomatic people are not allowed to enter our pharmacy.

Please contact your physician to discuss your eligibility for publicly-funded Paxlovid™:  

1. A positive COVID-19 test result (PCR or rapid antigen test self-administered at home or by a healthcare professional) -AND-

2. You will be starting Paxlovid™ treatment within 5 days of symptom onset -AND-

3. One of the following factors applies to you:

a. You are 18 years of age or older and is immunocompromised

b. You are 70 years of age or older

c. You are 60 years of age or older and have received less than 3 doses of a COVID-19 vaccine

d. You are 18 years of age or older, have received less than 3 doses of COVID-19 vaccine, and have at least one of the following risk conditions:

• obesity

• diabetes

• heart disease, hypertension, congestive heart failure

• chronic respiratory disease (including cystic fibrosis)

• cerebral palsy

• intellectual and developmental disabilities

• sickle cell disease

• moderate or severe kidney disease

• moderate or severe liver disease

• pregnant and unvaccinated (zero doses)

e. You are assessed as being at higher risk of severe COVID-19 based on your age, vaccination status, and risk conditions (excluding risks due to travel) by your prescriber.